Abstract
This paper reports a double-blind type of clinical trial with hyperactive low-grade mental defectives. Chlorpromazine has previously been used with this group but a high incidence of toxic effects has been noted (McColl (1)). Reports on reserpine have been conflicting but a careful trial by Kirk and Bauer (2) reports the action of this drug if anything to be detrimental.

This publication has 0 references indexed in Scilit: